Oxidized phosphatidylcholine formation and action in oligodendrocytes

Journal of Neurochemistry

Volumn 110, Issue 5, 2009, Pages 1388-1399

  Qin, Jingdong ^a   Testai, Fernando D ^b   Dawson, Sylvia ^a   Kilkus, John ^a   Dawson, Glyn ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Caspases; Oligodendroytes; Oxidized phosphatidylcholine; Peroxides; Sphingomyelinases

Indexed keywords

1 PALMITOYL 2 (5' OXO)VALERYL SN GLYCERO 3 PHOSPHORYLCHOLINE; CASPASE 3; CASPASE 8; CASPASE 8 INHIBITOR; CERAMIDE DERIVATIVE; HYDROGEN PEROXIDE; PHOSPHATIDYLCHOLINE; PHOSPHORYLCHOLINE; PROTEIN KINASE B; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; RAT;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; HUMANS; HYDROGEN PEROXIDE; OLIGODENDROGLIA; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES; PHOSPHOLIPID ETHERS; RATS;

RATTUS;

EID: 68949201124     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06231.x     Document Type: Article

References (55)

1. Berger A. B., Sexton K. B. Bogyo M. (2006) Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res. 16, 961 963.
2. Berlett B. S. Stadtman E. R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272, 20313 20316.
3. Birukova A. A., Alekseeva E., Cokic I., Turner C. E. Birukov K. G. (2008) Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids Amer. J. Physiol. 295, L593 L560.
4. Bizzozero O. A., DeJesus G., Callahan K. Pastuszyn A. (2005) Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis. J. Neurosci. Res. 81, 687 695.
5. Bottenstein J. E. (1986) Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes. Proc. Natl Acad. Sci. USA 83, 1955 1959.
6. Boullier A., Friedman P., Harkewicz R., Hartvigsen K., Green S. R., Almazan F., Dennis E. A., Steinberg D., Witztum J. L. Quehenberger O. (2005) Phosphocholine as a pattern recognition ligand for CD36. J. Lipid Res. 46, 969 976.
7. Buntinx M., Vanderlocht J., Hellings N., Vandenabeele F., Lambrichts I., Raus J., Ameloot M., Stinissen P. Steels P. (2003) Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J. Neurocytol. 32, 25 38.
8. Chalfant C. E., Rathman K., Pinkerman R. L., Wood R. E., Obeid L. M., Ogretmen B. Hannun Y. A. (2002) De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277, 12587 12595.
9. Chang M. K., Binder C. J., Miller Y. I., Subbanagounder G., Silverman G. J., Berliner J. A. Witztum J. L. (2004) Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200, 1359 1370.
10. Chen S., Lee J. M., Zeng C., Chen H., Hsu C. Y. Xu J. (2006) Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes. J. Neurochem. 97, 631 640.
11. Chen R., Yang L. McIntyre T. M. (2007) Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade. J. Biol. Chem. 282, 24850 24852.
12. Chudakova D. A., Zeidan Y. H., Wheeler B., Yu J., Novgorodov S. A., Kindy M. S., Hannun Y. A. Gudz T. I. (2008) Integrin-associated Lyn Kinase promotes cell survival by suppressing acid sphingomyelinase activity. J. Biol. Chem. 283, 28806 28816.
13. Dawson G., Moskal J. R. Dawson S. A. (2004) Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death. J. Neurochem. 89 (6 1436 1444.
14. Edelstein C., Pfaffinger D., Hinman J., Miller E., Lipkind G., Tsimikas S., Bergmark C., Getz G. S., Witztum J. L. Scanu A. M. (2003) Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). J. Biol. Chem. 278, 52841 52847.
15. Friedman P., Horkko S., Steinberg D., Witztum J. L. Dennis E. A. (2002) Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation. J. Biol. Chem. 277, 7010 7020.
16. Fruhwirth G. O., Moumtzi A., Loidl A., Ingolic E. Hermetter A. (2006) The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells. Biochim. Biophys. Acta 1761, 1060 1069.
17. Goswami R. Dawson G. (2000) Does ceramide play a role in neural cell apoptosis. J. Neurosci. Res. 60, 141 149.
18. Goswami R., Kilkus J., Dawson S. A. Dawson G. (1999) Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli. J. Neurosci. Res. 57, 884 893.
19. Goswami R., Ahmed M., Kilkus T., Dawson S. A. Dawson G. (2005) Differential regulation of ceramide in lipid-rich microdomains (Rafts): antagonistic role of palmotoyl:protein thioesterase and neutral sphingomyelinase 2. J. Neurosci. Res. 81, 208 217.
20. Gulbins E. Kolesnick R. (2002) Acid sphingomyelinase-derived ceramide signaling in apoptosis. Subcell. Biochem. 36, 229 244.
21. Jana A. Pahan K. (2007) Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: Implications for multiple sclerosis. J. Neuroimmun. Pharmacol. 2, 184 193.
22. Karakashian A. A., Giltiay N. V., Smith G. M. Nikolova-Karakashian M. N. (2004) Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation. FASEB J. 18, 968 970.
23. Kilkus J., Goswami R., Testai F. D. Dawson G. (2003) Ceramide in rafts (detergent-insoluble fraction) mediates cell death in neurotumor cell lines. J. Neurosci. Res. 72, 65 75.
24. Kilkus J., Goswami R., Dawson S. A., Testai F. D., Berdyshev E., Han X. Dawson G. (2008) Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons. J. Neurochem. 106, 1745 1757.
25. Kolesnick R. Hannun Y. A. (1999) Ceramide and apoptosis. Trends Biochem. Sci. 24, 224 225 author reply 227.
26. Lee J. T., Xu J. Hsu C. Y. (2004) Amyloid beta-peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164, 123 131.
27. Leitinger N. (2005) Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol. Nutr. Food Res. 49, 1063 1071.
28. Li R., Mouillesseaux K. P., Montoya D., Cruz D., Gharavi N., Dun M., Koroniak L. Berliner J. A. (2006) Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ. Res. 98, 642 650.
29. Loidl A., Sevcsik E., Riesenhuber G., Deigner H. P. Hermetter A. (2003) Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J. Biol. Chem. 278, 32921 32928.
30. Ma Z., Li J., Yang L., Mu Y., Xie W., Pitt B. Li S. (2004) Inhibition of LPS-and CpG DNA-induced TNF-alpha response by oxidized phospholipids. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L808 L816.
31. Marchesini N., Luberto C. Hannun Y. A. (2003) Biochemical properties of mammalian neutral sphingomyelinase2 and its role in sphingolipid metabolism. J. Biol. Chem. 278, 13775 13783.
32. McCarthy K. de Vellis. J. (1980) Preparation of separate astroglial and oligodendrogial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890 902.
33. Nonas S., Miller I., Kawkitinarong K., Chatchavalvanich S., Gorshkova I., Bochkov V. N., Leitinger N., Natarajan V., Garcia J. G. Birukov K. G. (2006) Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury. Am. J. Respir. Crit. Care Med. 173, 1130 1138.
34. Papa S., Zazzeroni F., Pham C. G., Bubuci C. Franzoso G. (2004) Linking JNK signaling to NF-kB: a key to survival. J. Cell Sci. 117, 5197 5208.
35. Pegorier S., Stengel D., Durand H., Croset M. Ninio E. (2006) Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis. Atherosclerosis 188, 433 443.
36. Post G. R. Dawson G. (1992) Characterization of a cell line derived from a human oligodendroglioma. Mol. Chem. Neuropathol. 16, 303 317.
37. Puranam K., Qian W. H., Nikbakht K., Venable M., Obeid L., Hannun Y. Boustany R. M. (1997) Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics 28, 37 41.
38. Qin J., Goswami R., Balabanov R. Dawson G. (2007) Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J. Neurosci. Res. 85, 977 984.
39. Qin J., Goswami R., Dawson S. Dawson G. (2008) Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress. J. Neurosci. Res. 86, 2414 2422.
40. Scurlock B. Dawson G. (1999) Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J. Neurosci. Res. 55, 514 522.
41. Shaw P. X., Hörkkö S., Chang M. K., Curtiss L. K., Palinski W., Silverman G. J. Witztum J. L. (2000) Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105, 1731 1740.
42. Siskind L. J., Kolesnick R. J. Colombini M. (2006) Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 6, 118 125.
43. Tafesse F. G., Ternes P. Holthuis J. C. (2006) The multigenic sphingomyelin synthase family. J. Biol. Chem. 281 (40 29421 29425.
44. Tafesse F. G., Huitema K. Holthuis J. C. M. (2007) Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells. J. Biol. Chem. 282, 17537 17547.
45. Taguchi Y., Kondo T., Watanabe M., Miyaji M., Umehara H., Kozutsumi Y. Okazaki T. (2004) Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3-kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase and glucosylceramide synthase. Blood 104, 3285 3293.
46. Tani M. Hannun Y. A. (2007) Neutral Sphingomyelinase 2 is palmitoylated on multiple cysteine residues. J. Biol. Chem. 282, 10047 10056.
47. Testai F. D., Landek M. A. Dawson G. (2004a) Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. J. Neurosci. Res. 75, 66 74.
48. Testai F. D., Landek M. A., Goswami R., Ahmed M. Dawson G. (2004b) Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidylmyo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling. J. Neurochem. 89, 636 644.
49. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., Schwille P., Brugger B. Simons M. (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244 1247.
50. Venkataraman K. Futerman A. H. (2000) Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol. 10, 408 412.
51. Walton K. A., Gugiu B. G., Thomas M., Basseri R. J., Eliav D. R., Salomon R. G. Berliner J. A. (2006) A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J. Lipid Res. 47, 1067 1974.
52. Weisner D. A. Dawson G. (1996) Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66, 1418 1425.
53. Wiesner D. A., Kilkus J. P., Gottschalk A. R., Quintans J. Dawson G. (1997) Antiimmunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J. Biol. Chem. 272, 9868 9876.
54. Yamaoka S. T., Miyaji M., Kitano Y., Umehara H. Okazaki T. (2004) Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J. Biol. Chem. 279, 18688 18693.
55. Yu Z. F., Nikolova-Karakashian M., Zhou D., Cheng G., Schuchman E. H. Mattson M. P. (2000) Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J. Mol. Neurosci. 15, 85 97.